NCT05021120 2025-12-04
A Study to Evaluate the Safety, Pharmacokinetics, and Antitumor Activity of AK127 in Combination With AK104 in Advanced and Metastatic Solid Tumours
Akeso
Phase EARLY_PHASE1 Completed
Clinical Trials
10 trialsNCT05908773 2025-01-28
A Microdose Study of TTX-MC138-NODAGA-Cu64 in Subjects With Advanced Solid Tumors
TransCode Therapeutics
Phase EARLY_PHASE1 Completed
NCT04552418 2024-02-28
Intestinal Microbiome Modification With Resistant Starch in Patients Treated With Dual Immune Checkpoint Inhibitors
University of Michigan Rogel Cancer Center
Phase EARLY_PHASE1 Completed
NCT05126927 2023-04-12
A PET Imaging Agent to Assess the Level of Tumor Tissue-infiltrating CD8 + T Cells in Patients With Solid Tumors
SmartNuclide Biopharma
Phase EARLY_PHASE1 Completed
NCT04056026 2019-09-23
A Single Dose FMT Infusion as an Adjunct to Keytruda for Metastatic Mesothelioma
ProgenaBiome
Phase EARLY_PHASE1 Completed
NCT01722149 2019-08-07
Re-directed T Cells for the Treatment (FAP)-Positive Malignant Pleural Mesothelioma
University of Zurich
Phase EARLY_PHASE1 Completed
NCT04046016 2019-08-06
A Study Using Whole-body PET After Oral Microdose of 18F-labeled Liporaxel in Patients With Solid Tumor
Seoul National University Hospital
Phase EARLY_PHASE1 Completed
NCT02157831 2018-08-17
Redosing With CP-870, 893 in Patients With Clinical Benefit After a Single Infusion From A Phase I, Open-Label, Dose-Escalation Study of CP-870,893 in Patients With Solid Tumors
Abramson Cancer Center at Penn Medicine
Phase EARLY_PHASE1 Completed
NCT00816335 2016-04-04
Fludeoxyglucose F 18 PET/CT Imaging in Finding Cancer in Patients Undergoing Surgery for Solid Tumors
Ohio State University Comprehensive Cancer Center
Phase EARLY_PHASE1 Completed
NCT00583063 2013-06-12
Interaction Study of Rapamycin and Sunitinib in Patients With Advanced Cancers
University of Chicago
Phase EARLY_PHASE1 Completed